ClinicalTrials.gov
public full text
Public Domain
DAOIB for the Treatment of Brain Fog
This is a 24-week open trial. We will enroll long-COVID patients with cognitive impairments. All patients will receive DAOIB for 24 weeks. We will assess the patients every 8 weeks during the treatment period (weeks 0, 8, 16, and 24). We hypothesize that DAOIB treatment will be beneficial in improving the cognitive function, mood symptoms, global functioning and quality of life in long-COVID patients with cognitive impairments.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Stimulation of the Thalamus to Ameliorate Persistent Disfluency#851247
- Combination Therapy for the Treatment of Diffuse Midline Gliomas#1127068
- BrainTwin-AI: A Multimodal MRI-EEG-Based Cognitive Digital Twin for Real-Time Brain Health Intelligence.#143447
- Safety and Preliminary Efficacy of NXL-001 in Patients With Ischemic Stroke#981351
- OCT-based DAPT Cessation in HBR Patients#435667
Record · ID 915053
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive